Invimestrocel for Acute ischaemic stroke

Invimestrocel is in clinical development for the treatment of acute ischaemic stroke within 18-36
hours of onset. Ischaemic stroke is the most common type of stroke. It happens when a blood
vessel is blocked by a blood clot, cutting off blood flow to part of the brain (ischaemia). Without
blood supply, brain cells can be damaged or destroyed due to lack of oxygen. Symptoms may
include numbness or weakness on one side of the body and problems with balance, speech and
swallowing. Symptoms may range from mild, through to severe strokes that can lead to long-term
disability, coma and death. While there are some treatments available for ischemic stroke,
patients must receive these treatments within only a few hours of having a stroke.